Clinical Trials Browser

Phase 1 × Sarcoma, Ewing × regorafenib × Clear all

NCT05830084 2026-01-06

REGO-INTER-EWI

Phase 1 Active not recruiting

Sarcoma, Ewing

NCT02085148 2024-04-22

A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy

Phase 1 Completed

CNSGastrointestinalGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma